Literature DB >> 23326127

Magnetic resonance-based total liver volume and magnetic resonance-diffusion weighted imaging for staging liver fibrosis in mini-pigs.

Hang Li1, Tian-Wu Chen, Xiao-Li Chen, Xiao-Ming Zhang, Zhen-Lin Li, Nan-Lin Zeng, Li Zhou, Li-Ying Wang, Hong-Jie Tang, Chun-Ping Li, Li Li, Xian-Yong Xie.   

Abstract

AIM: To determine whether and how magnetic resonance imaging (MRI)-based total liver volume (TLV) and diffusion weighted imaging (DWI) could predict liver fibrosis.
METHODS: Sixteen experimental mature mini-pigs (6 males, 10 females), weighing between 20.0 and 24.0 kg were prospectively used to model liver fibrosis induced by intraperitoneal injection of 40% CCl(4) dissolved in fat emulsion twice a week for 16 wk, and by feeding 40% CCl(4) mixed with maize flour twice daily for the subsequent 5 wk. All the survival animals underwent percutaneous liver biopsy and DWI using b = 300, 500 and 800 s/mm(2) followed by abdominal gadolinium-enhanced MRI at the 0, 5th, 9th, 16th and 21st weekend after beginning of the modeling. TLV was obtained on enhanced MRI, and apparent diffusion coefficient (ADC) was obtained on DWI. Hepatic tissue specimens were stained with hematoxylin and Masson's trichrome staining for staging liver fibrosis. Pathological specimens were scored using the human METAVIR classification system. Statistical analyses were performed to determine whether and how the TLV and ADC could be used to predict the stage of liver fibrosis.
RESULTS: TLV increased from stage 0 to 2 and decreased from stage 3 (r = 0.211; P < 0.001). There was a difference in TLV between stage 0-1 and 2-4 (P = 0.03) whereas no difference between stage 0-2 and 3-4 (P = 0.71). TLV could predict stage ≥ 2 [area under receiver operating characteristic curve (AUC) = 0.682]. There was a decrease in ADC values with increasing stage of fibrosis for b = 300, 500 and 800 s/mm(2) (r = -0.418, -0.535 and -0.622, respectively; all P < 0.001). Differences were found between stage 0-1 and 2-4 in ADC values for b = 300, 500 and 800 s/mm(2), and between stage 0-2 and 3-4 for b = 500 or 800 s/mm(2) (all P < 0.05). For predicting stage ≥ 2 and ≥ 3, AUC was 0.803 and 0.847 for b = 500 s/mm(2), and 0.848 and 0.887 for b = 800 s/mm(2), respectively.
CONCLUSION: ADC for b = 500 or 800 s/mm(2) could be better than TLV and ADC for b = 300 s/mm(2) to predict fibrosis stage ≥ 2 or ≥ 3.

Entities:  

Keywords:  Apparent diffusion coefficient; Liver fibrosis; Magnetic resonance imaging; Stage; Total liver volume

Mesh:

Substances:

Year:  2012        PMID: 23326127      PMCID: PMC3544024          DOI: 10.3748/wjg.v18.i48.7225

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Reversibility of cirrhosis in autoimmune hepatitis.

Authors:  Reza Malekzadeh; Mehdi Mohamadnejad; Siavosh Nasseri-Moghaddam; Nasser Rakhshani; Seyed Mohamad Tavangar; Amir Ali Sohrabpour; Soosan Tahaghoghi
Journal:  Am J Med       Date:  2004-07-15       Impact factor: 4.965

2.  Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

Authors:  R D Goldin; J G Goldin; A D Burt; P A Dhillon; S Hubscher; J Wyatt; N Patel
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

3.  The diffusion parameter in magnetic resonance: physics, techniques, and semeiotics.

Authors:  S Colagrande; S Pallotta; A Vanzulli; M Napolitano; N Villari
Journal:  Radiol Med       Date:  2005 Jan-Feb       Impact factor: 3.469

4.  Influence of perfusion on hepatic MR diffusion measurement.

Authors:  K G Hollingsworth; D J Lomas
Journal:  NMR Biomed       Date:  2006-04       Impact factor: 4.044

5.  Single-shot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phased-array multicoil.

Authors:  Y Amano; T Kumazaki; M Ishihara
Journal:  Acta Radiol       Date:  1998-07       Impact factor: 1.990

6.  Value of liver biopsy prior to interferon therapy for chronic viral hepatitis.

Authors:  T Heintges; L Mohr; F Hensel; W Petry; F Borchard; D Häussinger; C Niederau
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

7.  Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis.

Authors:  A Bosma; A Brouwer; W F Seifert; D L Knook
Journal:  J Pathol       Date:  1988-09       Impact factor: 7.996

8.  Diffusion-weighted single-shot echoplanar MR imaging for liver disease.

Authors:  T Kim; T Murakami; S Takahashi; M Hori; K Tsuda; H Nakamura
Journal:  AJR Am J Roentgenol       Date:  1999-08       Impact factor: 3.959

9.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

10.  Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

Authors: 
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

View more
  6 in total

1.  Apparent diffusion coefficient measurements and Gd-DTPA enhanced-imaging in staging hepatic fibrosis in rats.

Authors:  Yi-Ping Zhao; Dong-Mei Guo; Hui Liu; Wen-Hong Liu; Wen-Ying Mu; Peng Zhang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Liver Lobe Based Multi-Echo Gradient Recalled Echo T2*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis.

Authors:  Dan Wang; Tian-Wu Chen; Xiao-Ming Zhang; Jie Li; Nan-Lin Zeng; Li Li; Yu-Lian Tang; Yu-Cheng Huang; Rui Li; Fan Chen; Yan-Li Chen
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

3.  Diffusion tensor imaging quantifying the severity of chronic hepatitis in rats.

Authors:  Mengping Huang; Xin Lu; Xiaofeng Wang; Jian Shu
Journal:  BMC Med Imaging       Date:  2020-07-02       Impact factor: 1.930

4.  Magnetic resonance quantification of non-Gaussian water diffusion in hepatic fibrosis staging: a pilot study of diffusion kurtosis imaging to identify reversible hepatic fibrosis.

Authors:  Tang Liu; Jiawei Hu; Yajie Liu; Honghai Chen; Dongmei Guo
Journal:  Ann Transl Med       Date:  2021-10

5.  Liver lobe-based magnetic resonance diffusion-weighted imaging using multiple b values in patients with hepatitis B-related liver cirrhosis: association with the liver disease severity according to the Child-Pugh class.

Authors:  Hong-Jie Tang; Li Zhou; Xiao-Ming Zhang; Jun Liu; Tian-Wu Chen; Nan-Lin Zeng; Dan Wang; Jie Li; Yu-Cheng Huang; Yu-Lian Tang; Jiani Hu
Journal:  Clinics (Sao Paulo)       Date:  2015-07-01       Impact factor: 2.365

6.  Liver lobe volumes and the ratios of liver lobe volumes to spleen volume on magnetic resonance imaging for staging liver fibrosis in a minipig model.

Authors:  Hang Li; Tian-wu Chen; Xiao-ming Zhang; Zhen-lin Li; Jin-ling Zhang; Dan Wang; Ting Li; Jian-lin Wu; Xing Guo; Xiao-li Chen; Li Li; Xian-yong Xie; Zi-shu Zhang
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.